Sridhar Sethuraman

About Sridhar Sethuraman

Experienced Finance Executive in the Specialty Pharma / Biotech / Medical Devices industry with broad Finance and Operations expertise across multiple areas. Proven track record of delivering results across multiple functional areas with a focus on achieving corporate goals. Have a strategic mindset, developed strategic scenarios and evaluated Business Development deals across US and International markets. Concepts that drive my thinking are: Economics, Cash Flow and Shareholder value. Drove cost optimization and cash preservation efforts throughout my career. Experience in mid size Pharma and Biotech including scaling from R&D to Commercial, leading Finance function in International markets (Revenue $20M-$150M) and FP & A in the US (Revenue:$200M-$7B) and pre-revenue Biotech. Developed and mentored high performing teams. Additional areas of expertise:FP & A: Strategic Planning, Budgeting, Forecasting, Close and Reporting across Clinical / R&D, Commercial and Corporate Finance at Revance Therapeutics, Inc and Allergan,Inc. Financing / Fund raising: Participated and Supported follow on Equity raise, ATM, Convertible Debt and Venture Debt of ~$900M. M&A: Developing models, Board presentations, Engaging with Advisors and Bankers, Due diligenceTreasury: Investment ManagementHeaded Finance teams in international markets including Japan, South Korea, India & South East Asia. Business Unit Controller- US Neurosciences, US Medical Dermatology, Managed Care CMO negotiationsEngagement with Executive Committee, Finance Committee and Board of Directors Financial Accounting, SOX/ internal controls and Audits Led quarter close process and met/ exceeded quarterly EPS guidance / targets for 28 consecutive quarters at Allergan,Inc.Education: Bachelors degree in Accounting, MBA from Hult International Business School, Boston and CMA from US and India.

Experience

1. Executive Director-finance, Head- Fp & a and Treasury

   Revance

   Dec 2017 — Present · San Francisco, CA, US

   1) Scaled FP & A team from pre-revenue R&D phase to Commercialization2) Finance lead on licensing and partnership deals3) Streamlines processes and models to support long range plans, annual plans and forecasts4) Drove discussions around Financing and participated / supported CFO on various financing options including Follow on, ATM, Convertible debt and Venture debt5) Led clinical trial benchmarking exercises in collaboration with Head of R & D6) Invested in FP & A technology and implemented dashboards

Education

• IMA | Institute of Management Accountants

  CMA, Certified Management Accountant

• Hult International Business School

  Executive MBA, Finance, Accounting, Management

  2018 — 2020

• Hult International Business School

  Executive MBA

  2020

• Institute of Cost Accountants of India

  Certification, Financial Management, Accounting and Analysis

• Hult International Business School

  EMBA

  2020

• University of Madras

  Bachelor’s Degree, Commerce, Economics and Financial Accounting

Skills

• Strategic Planning
• Forecasting
• Business Planning
• Business Strategy
• Pharmaceutical Industry
• Strategy
• Management
• Cross-Functional Team Leadership
• Product Launch
• Competitive Analysis
• Sales Effectiveness
• Pharmaceutical Sales
• Medical Devices
• Budgets
• Market Development
• Managerial Finance
• Business Development
• Sales Operations
• Sarbanes-Oxley Act
• Erp
• Financial Analysis
• Finance
• Leadership
• Accounting
• Budgeting
• Corporate Fp&a
• Financial Modeling
• Corporate Finance
• Financial Planning
• Internal Controls
• Mergers & Acquisitions
• Business Process Improvement
• Financial Reporting